fluoxetine has been researched along with Hot Flashes in 12 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Hot Flashes: A sudden, temporary sensation of heat predominantly experienced by some women during MENOPAUSE. (Random House Unabridged Dictionary, 2d ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| " With this in mind, a single-arm clinical trial low-dose regimen of Fluoxetine (10 mg/day for 4 weeks) was given to twenty symptomatic breast cancer patients." | 9.11 | Hot-flashes in breast cancer survivors: effectiveness of low-dosage fluoxetine. A pilot study. ( Atlante, M; Barbati, A; Galati, M; Giannarelli, D; Mariani, L; Quattrini, M, 2005) |
| "This trial used a double-blinded, randomized, two-period (4 weeks per period), cross-over methodology to study the efficacy of fluoxetine (20 mg/d) for treating hot flashes in women with a history of breast cancer or a concern regarding the use of estrogen (because of breast cancer risk)." | 9.10 | Phase III evaluation of fluoxetine for treatment of hot flashes. ( Halyard, MY; Loprinzi, CL; Mailliard, JA; Novotny, PJ; Perez, EA; Pruthi, S; Quella, SK; Rummans, TA; Sloan, JA; Stella, PJ, 2002) |
| " In both treatment rounds, gabapentin caused greater reductions in the severity of hot flashes than did fluoxetine (P<0." | 5.20 | A crossover study comparing gabapentin and fluoxetine for the treatment of vasomotor symptoms among postmenopausal women. ( Ghorbani, R; Mohseni, A; Rahmanian, M, 2015) |
| " With this in mind, a single-arm clinical trial low-dose regimen of Fluoxetine (10 mg/day for 4 weeks) was given to twenty symptomatic breast cancer patients." | 5.11 | Hot-flashes in breast cancer survivors: effectiveness of low-dosage fluoxetine. A pilot study. ( Atlante, M; Barbati, A; Galati, M; Giannarelli, D; Mariani, L; Quattrini, M, 2005) |
| "This trial used a double-blinded, randomized, two-period (4 weeks per period), cross-over methodology to study the efficacy of fluoxetine (20 mg/d) for treating hot flashes in women with a history of breast cancer or a concern regarding the use of estrogen (because of breast cancer risk)." | 5.10 | Phase III evaluation of fluoxetine for treatment of hot flashes. ( Halyard, MY; Loprinzi, CL; Mailliard, JA; Novotny, PJ; Perez, EA; Pruthi, S; Quella, SK; Rummans, TA; Sloan, JA; Stella, PJ, 2002) |
| "Results from these trials indicate that paroxetine, citalopram, escitalopram, venlafaxine, and desvenlafaxine are effective in reducing the frequency and severity of hot flashes." | 4.91 | The efficacy and tolerability of SSRI/SNRIs in the treatment of vasomotor symptoms in menopausal women: a systematic review. ( Handley, AP; Williams, M, 2015) |
| "Migraine is affected by fluctuating estrogen levels so it is not surprising that the perimenopause is a time of peak rate of change of migraine prevalence in women." | 2.48 | Perimenopausal migraine in women with vasomotor symptoms. ( MacGregor, EA, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (58.33) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Handley, AP | 1 |
| Williams, M | 1 |
| Rahmanian, M | 1 |
| Mohseni, A | 1 |
| Ghorbani, R | 1 |
| Zhu, X | 1 |
| Liew, Y | 1 |
| Liu, ZL | 1 |
| MacGregor, EA | 1 |
| Prelle, K | 1 |
| Igl, BW | 1 |
| Obendorf, M | 1 |
| Girbig, D | 1 |
| Lehmann, T | 1 |
| Patchev, VK | 1 |
| Goetz, MP | 1 |
| Loprinzi, CL | 2 |
| Mariani, L | 1 |
| Quattrini, M | 1 |
| Atlante, M | 1 |
| Galati, M | 1 |
| Barbati, A | 1 |
| Giannarelli, D | 1 |
| Albertazzi, P | 1 |
| Maswood, N | 1 |
| Cosmi, S | 1 |
| Alfinito, PD | 1 |
| Leventhal, L | 1 |
| Deecher, DC | 1 |
| Alexander, IM | 1 |
| Moore, A | 1 |
| Sloan, JA | 1 |
| Perez, EA | 1 |
| Quella, SK | 1 |
| Stella, PJ | 1 |
| Mailliard, JA | 1 |
| Halyard, MY | 1 |
| Pruthi, S | 1 |
| Novotny, PJ | 1 |
| Rummans, TA | 1 |
6 reviews available for fluoxetine and Hot Flashes
| Article | Year |
|---|---|
The efficacy and tolerability of SSRI/SNRIs in the treatment of vasomotor symptoms in menopausal women: a systematic review.
Topics: Adult; Aged; Citalopram; Desvenlafaxine Succinate; Female; Fluoxetine; Hot Flashes; Humans; Menopaus | 2015 |
Chinese herbal medicine for menopausal symptoms.
Topics: Drugs, Chinese Herbal; Estazolam; Female; Fluoxetine; Hormone Replacement Therapy; Hot Flashes; Huma | 2016 |
Perimenopausal migraine in women with vasomotor symptoms.
Topics: Amines; Cyclohexanecarboxylic Acids; Estrogen Replacement Therapy; Estrogens; Female; Fluoxetine; Ga | 2012 |
A hot flash on tamoxifen metabolism.
Topics: Antidepressive Agents, Second-Generation; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cyclohe | 2003 |
Noradrenergic and serotonergic modulation to treat vasomotor symptoms.
Topics: Citalopram; Cyclohexanols; Female; Fluoxetine; Hot Flashes; Humans; Menopause; Mianserin; Mirtazapin | 2006 |
Treating vasomotor symptoms of menopause: the nurse practitioner's perspective.
Topics: Adrenergic alpha-Agonists; Algorithms; Amines; Citalopram; Clonidine; Complementary Therapies; Cyclo | 2007 |
3 trials available for fluoxetine and Hot Flashes
| Article | Year |
|---|---|
A crossover study comparing gabapentin and fluoxetine for the treatment of vasomotor symptoms among postmenopausal women.
Topics: Amines; Cross-Over Studies; Cyclohexanecarboxylic Acids; Excitatory Amino Acid Antagonists; Female; | 2015 |
Hot-flashes in breast cancer survivors: effectiveness of low-dosage fluoxetine. A pilot study.
Topics: Adult; Breast Neoplasms; Dose-Response Relationship, Drug; Female; Fluoxetine; Hot Flashes; Humans; | 2005 |
Phase III evaluation of fluoxetine for treatment of hot flashes.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Bayes Theorem; Breast Neoplasms; Chi-Square D | 2002 |
3 other studies available for fluoxetine and Hot Flashes
| Article | Year |
|---|---|
Endpoints of drug discovery for menopausal vasomotor symptoms: interpretation of data from a proxy of disease.
Topics: Acetamides; Amines; Animals; Body Temperature Regulation; Cyclohexanecarboxylic Acids; Cyclohexanols | 2012 |
Treating hot flashes with drugs: an update.
Topics: Acetates; Amines; Anticonvulsants; Antidepressive Agents, Second-Generation; Antihypertensive Agents | 2002 |
The role of the selective serotonin reuptake inhibitor fluoxetine in temperature regulation in ovariectomized rat models.
Topics: Animals; Body Temperature Regulation; Disease Models, Animal; Dose-Response Relationship, Drug; Drug | 2006 |